EP0264429A4 - PROCEDE ENZYMATIQUE POUR LA PREPARATION DE DERIVES DE L'ACIDE 1,2-DIHYDRO-3H-PYROLLO 1,2a]PYRROLE-1-CARBOXYLIQUE OPTIQUEMENT ACTIFS. - Google Patents
PROCEDE ENZYMATIQUE POUR LA PREPARATION DE DERIVES DE L'ACIDE 1,2-DIHYDRO-3H-PYROLLO 1,2a]PYRROLE-1-CARBOXYLIQUE OPTIQUEMENT ACTIFS.Info
- Publication number
- EP0264429A4 EP0264429A4 EP19870903014 EP87903014A EP0264429A4 EP 0264429 A4 EP0264429 A4 EP 0264429A4 EP 19870903014 EP19870903014 EP 19870903014 EP 87903014 A EP87903014 A EP 87903014A EP 0264429 A4 EP0264429 A4 EP 0264429A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- dihydro
- pyrrole
- pyrrolo
- ester
- lipase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000002255 enzymatic effect Effects 0.000 title claims description 6
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- FDDQRDMHICUGQC-UHFFFAOYSA-N pyrrole-1-carboxylic acid Chemical class OC(=O)N1C=CC=C1 FDDQRDMHICUGQC-UHFFFAOYSA-N 0.000 title abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 71
- 108090001060 Lipase Proteins 0.000 claims abstract description 29
- 230000008569 process Effects 0.000 claims abstract description 29
- 108091005804 Peptidases Proteins 0.000 claims abstract description 24
- 239000004365 Protease Substances 0.000 claims abstract description 24
- 230000000813 microbial effect Effects 0.000 claims abstract description 6
- 102100031375 Endothelial lipase Human genes 0.000 claims abstract description 3
- 101710158368 Extracellular lipase Proteins 0.000 claims abstract 2
- 101710128940 Triacylglycerol lipase Proteins 0.000 claims abstract 2
- 150000004702 methyl esters Chemical class 0.000 claims description 28
- 102000004190 Enzymes Human genes 0.000 claims description 27
- 108090000790 Enzymes Proteins 0.000 claims description 27
- 239000000758 substrate Substances 0.000 claims description 27
- 102000004882 Lipase Human genes 0.000 claims description 26
- 239000004367 Lipase Substances 0.000 claims description 26
- 235000019421 lipase Nutrition 0.000 claims description 26
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 17
- 150000002148 esters Chemical class 0.000 claims description 15
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- -1 methoxybenzoyl groups Chemical group 0.000 claims description 9
- 125000001999 4-Methoxybenzoyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C(*)=O 0.000 claims description 8
- 241000235395 Mucor Species 0.000 claims description 6
- 108010079522 solysime Proteins 0.000 claims description 5
- 241000228212 Aspergillus Species 0.000 claims description 4
- 241000589516 Pseudomonas Species 0.000 claims description 4
- 241000235527 Rhizopus Species 0.000 claims description 4
- 241000187392 Streptomyces griseus Species 0.000 claims description 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- 240000006439 Aspergillus oryzae Species 0.000 claims description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 230000003301 hydrolyzing effect Effects 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 241000131386 Aspergillus sojae Species 0.000 claims description 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 2
- 244000063299 Bacillus subtilis Species 0.000 claims description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 2
- 241000588881 Chromobacterium Species 0.000 claims description 2
- 241000228143 Penicillium Species 0.000 claims description 2
- 241000303962 Rhizopus delemar Species 0.000 claims description 2
- 241000187747 Streptomyces Species 0.000 claims description 2
- 241000179532 [Candida] cylindracea Species 0.000 claims description 2
- 239000012190 activator Substances 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 101710089384 Extracellular protease Proteins 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 102000035195 Peptidases Human genes 0.000 abstract description 7
- 230000007062 hydrolysis Effects 0.000 abstract description 5
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 7
- 238000010626 work up procedure Methods 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 6
- 241000228245 Aspergillus niger Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- 101000966371 Rhizopus niveus Lipase Proteins 0.000 description 2
- 101000966369 Rhizopus oryzae Lipase Proteins 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- VGLKHVQPWGFXEG-NCJHBDPTSA-K europium(3+);(1z)-2,2,3,3,4,4,4-heptafluoro-1-(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)butan-1-olate Chemical compound [Eu+3].C1CC2(C)C(=O)\C(=C(/[O-])C(F)(F)C(F)(F)C(F)(F)F)C1C2(C)C.C1CC2(C)C(=O)\C(=C(/[O-])C(F)(F)C(F)(F)C(F)(F)F)C1C2(C)C.C1CC2(C)C(=O)\C(=C(/[O-])C(F)(F)C(F)(F)C(F)(F)F)C1C2(C)C VGLKHVQPWGFXEG-NCJHBDPTSA-K 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- HEOZYYOUKGGSBJ-UHFFFAOYSA-N 5-(4-methoxybenzoyl)-2,3-dihydro-1h-pyrrolizine-1-carboxylic acid Chemical compound C1=CC(OC)=CC=C1C(=O)C1=CC=C2N1CCC2C(O)=O HEOZYYOUKGGSBJ-UHFFFAOYSA-N 0.000 description 1
- 240000008791 Antiaris toxicaria Species 0.000 description 1
- 241000228251 Aspergillus phoenicis Species 0.000 description 1
- 241000588879 Chromobacterium violaceum Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 244000168141 Geotrichum candidum Species 0.000 description 1
- 235000017388 Geotrichum candidum Nutrition 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 241001507683 Penicillium aurantiogriseum Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 241000952054 Rhizopus sp. Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000223258 Thermomyces lanuginosus Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229950004699 anirolac Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- KMPWYEUPVWOPIM-KODHJQJWSA-N cinchonidine Chemical class C1=CC=C2C([C@H]([C@H]3[N@]4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-KODHJQJWSA-N 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960004752 ketorolac Drugs 0.000 description 1
- OZWKMVRBQXNZKK-UHFFFAOYSA-M ketorolac(1-) Chemical compound [O-]C(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-M 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- GREBGQSAVFHEAD-UHFFFAOYSA-N methyl 5-benzoyl-2,3-dihydro-1h-pyrrolizine-1-carboxylate Chemical compound COC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 GREBGQSAVFHEAD-UHFFFAOYSA-N 0.000 description 1
- 229960004715 morphine sulfate Drugs 0.000 description 1
- GRVOTVYEFDAHCL-RTSZDRIGSA-N morphine sulfate pentahydrate Chemical compound O.O.O.O.O.OS(O)(=O)=O.O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O.O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O GRVOTVYEFDAHCL-RTSZDRIGSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108010043393 protease N Proteins 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- WUUHFRRPHJEEKV-UHFFFAOYSA-N tripotassium borate Chemical compound [K+].[K+].[K+].[O-]B([O-])[O-] WUUHFRRPHJEEKV-UHFFFAOYSA-N 0.000 description 1
- ZXVNMYWKKDOREA-UHFFFAOYSA-N zomepirac Chemical compound C1=C(CC(O)=O)N(C)C(C(=O)C=2C=CC(Cl)=CC=2)=C1C ZXVNMYWKKDOREA-UHFFFAOYSA-N 0.000 description 1
- 229960003414 zomepirac Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
Definitions
- the present invention relates to a novel process for producing optically-active 1,2-dihydro-3H-pyrrolo[1,2a] ⁇ yrrole-1- carboxylic acid derivatives. Specifically, it relates to a process for the enzymatic enantiospedfic hydrolysis of racemic 1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid esters to give optically-active 1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1- carboxylic acids.
- Ketorolac 5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1- carboxylic acid (1), a structural analog of zomepirac [J. Clin. Pharmacol., 20, 213 (1980)], is a potent antiinflammatory and analgesic agent in animal models [W. H. Rooks et al., Agents Actions, 12, 684 (1982)]. In humans, it is essentially equivalent to morphine sulfate for the relief of postoperative pain [J. Yee et al., Clin. Pharmacol. Ther., 35, 285 (1984)]. More recently, it was reported [A. Guzman et al., J. Wed. Chem., 29, 589 (1986)] that the (-)-S-isomer of ketorolac (1) is about 60- 230 times more potent than the (+)-R-isomer in animal model studies.
- this invention comprises the use of extracellular microbial enzymes selected from the group consisting of lipases and proteases to catalyze the enantiospedfic hydrolysis of racemic 1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid esters as hereinbelow defined.
- R 1 is a radical in straight chain, branched chain, or cyclic configuration selected from the class consisting of alkane radicals having from 1 to about 12 carbon atoms with or without electronegative substituents at C-2'; cycloalkane radicals having from about 5 to about 7 carbon atoms; phenyl and benzyl radicals having from about 6 to about 8 carbon atoms; (examples of electronegative substituents of the alkane radicals referred to above are radicals such as halogens, nitro groups, nitriles, and carboxylates);
- R 2 is an acyl radical in straight chain, branched chain or cyclic configuration having 2 to about 12 carbon atoms, cycloalkane radicals having about 5 to about 7 carbon atoms, benzoyl, naphthoyl, biphenoyl, and carbobenzoxy radicals containing nitro, halogen, methyl, or alkoxy groups in the aromatic ring.
- aroyl radicals which are eminently suitable for the purposes of the present invention are benzoyl and methoxybenzoyl.
- Another object of the present invention is to provide an improved process for preparing the optically-active (-)-S-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid (1) using extracellular inexpensive microbial upases and proteases.
- the process of the invention comprises subjecting said 1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic ester to the hydrolytic action of a microbial lipase (EC 3.1.1.3) or protease and recovering the desired optically-active 1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid derivatives.
- a microbial lipase EC 3.1.1.3
- protease microbial lipase
- extracellular microbial lipases and proteases are capable ,of functioning to catalyze the desired enantiospedfic hydrolysis.
- lipases derived from the microorganisms of the genera Candida, Rhizopus, Hucor. Aspergillus. Penicillium, Geotrichium, Hurmicola, Pseudomonas and Chromobacterium.
- proteases are those derived from the genera Streptomyces, Bacillus, Aspergillus, Rhizopus.
- Extracellular microbial lipases are well known and many of these are available commercially (see M. Iwai and Y. Tsujsaka, page 443, and M. Sugiura, page 505, in "Lipases,” edited by B. Borgström and H. L. Brockman, Elsevier, N.Y., 1984). For example, they are used industrially for the transesterification of fats and were incorporated in laundry detergents for removal of oily contaminants.
- Extracellular bacterial, mold, and yeast proteases are well documented in the literature (see H. Matsubara and J. Feder, p. 721, in “Enzymes,” Vol. Ill, P. D. Boyer (ed.), Academic Press, N.Y., 1971).
- the 1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic ester substrate may be added in solid or liquid forms at concentrations of 0.1-5 M to a suitable buffer solution containing the lipase to effect the enantiospedfic hydrolysis.
- the substrate can be dissolved in a suitable organic solvent such as carbon tetrachloride, cyclohexane, carbon disulfide, or hexane, as long as the solvent does not denature the enzyme.
- the substrate may be emulsified by the use of polyvinyl alcohol or propylene glycol.
- the temperature and pressure conditions under which the ester substrate and the lipase are brought into contact are interdependent as will be apparent to those skilled in the art.
- the temperature can range from about 10°C to about 40oC and the pH of the medium can range from 3 to about 8.5.
- esters of ( ⁇ )-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic esters which are to be resolved are prepared according to the procedures described by J. M. Muchowski et al., J. Med. Chem., 28, 1037 (1985), and H. Caspio et al., Can. J. Chem., 60, 2295 (1982).
- the enantiomeric excess (ee) of the remaining methyl ester and the acid (after treatment with diazomethane) were determined by PMR measurements using Eu(hfc) 3 .
- reaction mixture was stirred with a magnetic stirrer for 2 days at 24°C.
- contents were then acidified with HCl and exhaustively extracted with ethyl acetate three times.
- the combined organic extract was dried over sodium sulfate and was then evaporated to dryness.
- Example 1 The procedure of Example 1 is repeated except that ( ⁇ )-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic methyl ester is used as the substrate to obtain optically-active 1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid in good yield.
- Example 1 The procedure of Example 1 is repeated except that ( ⁇ )-5- [4-raethoxybenzoyl]-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic methyl ester is used as the substrate to obtain (+)-5-[4-methoxybenzoyl]-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid (anirolac) in good yield.
- EXAMPLE 4 The procedure of Example 1 is repeated except that ( ⁇ )-5- benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic chloroethyl ester is used as the substrate to obtain (+)-5-benzoyl- 1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid.
- Example 1 The procedure of Example 1 is repeated except that ( ⁇ )-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic dodecyl ester is used as the substrate to obtain (+)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid.
- Mucor meihei lipase Mano, 10,000 ILu/gm, MAP
- Example 9 The procedure of Example 2 is repeated except that 20 mg of Rhizopus oryzae lipase (Amano, 750,000 ILu/gm, FAP), is used as the enzyme to obtain optically-active 1,2-dihydro-3H-pyrrolo-[1,2a]pyrrole-1-carboxylic acid.
- Rhizopus oryzae lipase Mano, 750,000 ILu/gm, FAP
- Example 10 The procedure of Example 1 is repeated using 2500 units of Chromobacterium violaceum lipase (Type XII, Sigma) as the enzyme to obtain optically-active 5-benzoyl-1,2-dihydro-3H-pyrrolo-[1,2a]pyrrole-1-carboxylic acid.
- Chromobacterium violaceum lipase Type XII, Sigma
- Example 12 The procedure of Example 1 is repeated using 10 mg of purified Geotrichum candidum (ATCC 34614) lipase [Y. Tsujisaka et al., Agr. Biol. Chen., 37 1457 (1973)] as the enzyme to obtain optically-active 5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid.
- ATCC 34614 purified Geotrichum candidum lipase
- Example 1 The procedure of Example 1 is repeated using 200 mg of crude lipase of Penicillium cyclopium (ATCC 34613) [M. Iwai et al., Agr. Biol. Chea.. 39, 1063 (1975)] as the enzyme to obtain optically-active 5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid.
- Example 14 The procedure of Example 1 is repeated using 200 mg of Humicola lanuginosa lipase (Amano) as the enzyme to obtain optically-active 5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid.
- Humicola lanuginosa lipase Amano
- Example 2 The procedure of Example 2 is repeated using 200 mg of Mucor meihei lipase (Amano) as the enzyme to obtain opticallyactive 1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid.
- Mano Mucor meihei lipase
- Example 2 The procedure of Example 2 is repeated using 2,000 units of Rhizopus delemar lipase (Chemical Dynamics Corp., 5,000 units/ mg) as the enzyme to obtain optically-active 1 ,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid.
- Example 2 The procedure of Example 2 is repeated using Aspergillus niger lipase (100 mg) (Amano K-10) as the enzyme to obtain optically-active 1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid.
- EXAMPLE 20 The procedure of Example 2 is repeated using 30 mg of Pseudomonas lipase (Amano LPL-80) as the enzyme to obtain optically-active 1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid.
- EXAMPLE 21 The procedure of Example 3 is repeated using 100 mg of Rhizopus niveus lipase (Amano , N) as the enzyme to obtain optically-active 5-[4-methoxybenzoyl]-1 , 2-dihydro-3H-pyrrolo[1 , 2a]pyrrole-1-carboxylic acid.
- Example 3 The procedure of Example 3 is repeated using Aspergillus niger lipase (Amano AP, 120,000 Lu/gm) as the enzyme to obtain optically-active (+)-5-[4-methoxybenzoyl]-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid.
- Aspergillus niger lipase Aspergillus niger lipase (Amano AP, 120,000 Lu/gm) as the enzyme to obtain optically-active (+)-5-[4-methoxybenzoyl]-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid.
- Example 6 The procedure of Example 6 is repeated using 30 mg of Rhizopus oryzae lipase (Amano, FAP) as the enzyme to obtain optically-active (+)-5-[4-methoxybenzoyl]-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid.
- Rhizopus oryzae lipase Amano, FAP
- EXAMPLE 24 The procedure of Example 4 is repeated using 50 mg of Mucor meihei lipase (Amano, MAP) as the enzyme to obtain opticallyactive (+)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid.
- Mucor meihei lipase Amano, MAP
- EXAMPLE 25 The procedure of Example 5 is repeated using 50 mg of Mucor neihei lipase (Amano, MAP) as the enzyme to obtain opticallyactive 1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid.
- Mucor neihei lipase Amano, MAP
- Example 26 The procedure of Example 26 was repeated using 24 mg of Streptomyces griseus protease (Sigma type XIV, pronase E, P5147) and 110 mg of (+)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic methyl ester. The incubation mixture was stirred with a magnetic stirrer for 312 hrs at 25°C.
- Example 28 The procedure of Example 26 was repeated using 88 mg of Aspergillus saitoi protease (Sigma type XIII, 0.3 unit per mg solid, P2143) and 114 mg of (+)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrroIe-carboxylic methyl ester as the substrate. The reaction mixture was incubated at 25°C for 312 hrs with stirring using the same workup procedure.
- Aspergillus saitoi protease Sigma type XIII, 0.3 unit per mg solid, P2143
- (+)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrroIe-carboxylic methyl ester was incubated at 25°C for 312 hrs with stirring using the same workup procedure.
- Example 26 The procedure of Example 26 was repeated using 49 mg of Aspergillus sojae protease (Sigma Type XIX, 0.4 units per mg solid, P7026) and 147 mg of (+)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic methyl ester as the substrate. The reaction mixture was stirred at 25°C for 23 hrs.
- Example 26 The procedure of Example 26 was repeated using 62 mg of Rhizopus sp. protease (Sigma type XVIII, 0.5 unit per mg solid, P5027) and 117 mg of (+)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]-pyrrole-1-carboxylic methyl ester as the substrate. The reaction mixture was gently stirred at 25°C for 165 hrs.
- Example 26 The procedure of Example 26 was repeated using 75 mg of Aspergillus oryzae protease (Sigma type XXIII, 4 units per mg solid, P-4032) and 87 mg of (+)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic methyl ester as the substrate. The reaction mixture was gently stirred at 25°C for 23 hrs.
- Example 32 The procedure of Example 26 was repeated using 19 mg of Bacillus subtilis protease (Amano protease N, 1800 northrop units per gram) and 77 mg of ( ⁇ )-)-benzoyl-1,2-dihydro-3H-pyr rolo[1,2a]pyrrole-1-carboxylic methyl ester as the substrate. The reaction mixture was gently stirred at 25°C for 74 hrs.
- Example 26 The procedure of Example 26 was repeated using 30 mg of Aspergillus oryzae protease [Amano 2A fungal protease (neutral), 20,000 units/gm] and 85 mg of (+)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic methyl ester as the substrate.
- the reaction mixture was gently stirred at 25oC for 74 hrs.
- the process may be made continuous wherein the enzyme is immobilized and recycled several times to reduce cost; the (+)-ester can be recovered, racemized, and reused; or the substrate can be exposed to the enzyme as a microcrystalline powder to obtain better dispersion.
- it may be possible to dissolve the (+)-substrate and a racemization agent in a suitable solvent so only the ester will be continuously racemized in situ without cleaving the ester grouping.
- This not process not only facilitates product isolation but also is equivalent to second-order asymmetric transformation (Asymmetric Synthesis. Vol. 1, edited by J. D. Morris and J. W. Scott, Academic Press, Inc., N.Y., 1983, pp. 3-6). This is Illustrated by the procedure of Example 34.
- activators and stabilizers of the lipase may be introduced to the incubation mixture or substrates possessing many different types of activated esters (Bodanszky et al., Peptide Synthesis, Second Ed., Wiley, 1976, pp. 99-108) may be used to enhance the rate of conversion.
- active site directed mutagenesis or chemical modification of the enzyme may be used to prepare enzymes with improved V max /K m and/or stability.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85267786A | 1986-04-16 | 1986-04-16 | |
| US852677 | 1986-04-16 | ||
| US92806886A | 1986-11-06 | 1986-11-06 | |
| US928068 | 1986-11-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0264429A1 EP0264429A1 (fr) | 1988-04-27 |
| EP0264429A4 true EP0264429A4 (fr) | 1990-03-12 |
Family
ID=27127081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19870903014 Withdrawn EP0264429A4 (fr) | 1986-04-16 | 1987-04-02 | PROCEDE ENZYMATIQUE POUR LA PREPARATION DE DERIVES DE L'ACIDE 1,2-DIHYDRO-3H-PYROLLO 1,2a]PYRROLE-1-CARBOXYLIQUE OPTIQUEMENT ACTIFS. |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0264429A4 (fr) |
| JP (1) | JPH01500004A (fr) |
| KR (1) | KR880701287A (fr) |
| WO (1) | WO1987006266A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5464609A (en) * | 1990-03-16 | 1995-11-07 | The Procter & Gamble Company | Use of ketorolac for treatment of oral diseases and conditions |
| US5382591A (en) * | 1992-12-17 | 1995-01-17 | Sepracor Inc. | Antipyretic and analgesic methods using optically pure R-ketorolac |
| KR0140134B1 (ko) * | 1994-11-16 | 1998-06-01 | 강재헌 | 피롤리진 유도체의 제조방법 |
| ES2101653B1 (es) * | 1995-07-10 | 1998-04-01 | Asturpharma S A | (+)-6-(5-cloropirid-2-il)-7-oxo-viniloxicarboniloxi-5,6-dihidropirrolo(3,4b)pirazina y su uso para un procedimiento de preparacion de (+)-6-(5-cloropirid-2-il)-5-(4-metilpiperazin-1-il)-carboniloxi-7-oxo-5,6-dihidropirrolo(3,4b)pirazina. |
| CN115181105B (zh) * | 2022-08-26 | 2024-05-28 | 长春亿诺科医药科技有限责任公司 | R型酮咯酸的制备方法及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0197474B1 (fr) * | 1985-04-01 | 1991-07-10 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Procédé de préparation d'acide indoline-2-carboxylique optiquement actif |
| JPH07108958B2 (ja) * | 1993-09-01 | 1995-11-22 | 日本ペイント株式会社 | 撥水型防汚塗料組成物 |
-
1987
- 1987-04-02 WO PCT/US1987/000725 patent/WO1987006266A1/fr not_active Ceased
- 1987-04-02 EP EP19870903014 patent/EP0264429A4/fr not_active Withdrawn
- 1987-04-02 JP JP62502393A patent/JPH01500004A/ja active Pending
- 1987-04-02 KR KR1019870701173A patent/KR880701287A/ko not_active Withdrawn
Non-Patent Citations (2)
| Title |
|---|
| J. AM. CHEM. SOC., vol. 109, no. 9, 29th April 1987, pages 28452846, American Chemical Society, Austin, US; G. FÜLLING et al.: "Enzymatic second-order asymmetric hydrolysis of ketorolac esters: in situ racemization" * |
| See also references of WO8706266A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1987006266A1 (fr) | 1987-10-22 |
| EP0264429A1 (fr) | 1988-04-27 |
| JPH01500004A (ja) | 1989-01-12 |
| KR880701287A (ko) | 1988-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4629701A (en) | Process for preparing optically active carboxylic acids and antipode esters thereof | |
| FI95931B (fi) | Menetelmä (2R,3S)-3-(4-metoksifenyyli)glysidiinihapon alemman alkyyliesterin valmistamiseksi | |
| US5914263A (en) | Enzymatic process for the stereoselective preparation of a hetero-bicyclic alcohol enantiomer | |
| US5770438A (en) | Process for enantioselective hydrolysis of α-(2-amino)-phenyl-benzenemethanol ester type compounds using bacillus, pseudomonas or streptomyces | |
| JP2769194B2 (ja) | 酵素分解方法 | |
| WO1987006266A1 (fr) | PROCEDE ENZYMATIQUE POUR LA PREPARATION DE DERIVES DE L'ACIDE 1,2-DIHYDRO-3H-PYROLLO[1,2a]PYRROLE-1-CARBOXYLIQUE OPTIQUEMENT ACTIFS | |
| US6121025A (en) | Process for producing optically active 3-quinuclidinol derivatives | |
| CA2023856A1 (fr) | Procede de resolution enzymatique | |
| CN101652483B (zh) | 二酯化合物的化学选择性酶水解以制备单酸单酯化合物的方法 | |
| US5106736A (en) | Enzymatic process for enantiomer-specific perparation of mercapto alkanoic acid compounds | |
| EP0528607B1 (fr) | Procédé de préparation d'esters de l'acide 3-phényl-glycidiques optiquements actifs | |
| US5986095A (en) | Enantioselective preparation of halophenyl alcohols and acylates | |
| EP0259465A1 (fr) | Procede de preparation de derives de l'acide 3-acylthio-2-methylpropionic optiquement actifs | |
| JP4765358B2 (ja) | 光学活性なn−保護−プロパルギルグリシンの製造方法 | |
| JP3679819B2 (ja) | (s)−3−(2−チエニルチオ)ブタン酸の製造法 | |
| JPH1175889A (ja) | 光学活性α−トリフルオロメチル乳酸及びその対掌体エステルの製造方法及び精製方法 | |
| US5420037A (en) | Process for separation of enantiomeric 3-mercapto-2-substituted alkanoic acid using lipase P30 and synthesis of captopril type compounds | |
| JP2003520018A (ja) | 光学活性な1−アミノ−4−(ヒドロキシルメチル)−シクロペンタ−2−エン誘導体の製造方法 | |
| JPH0315398A (ja) | 光学活性3―フェニルグリシッド酸エステル類化合物の製法 | |
| JPH04356195A (ja) | アゼチジノン誘導体の製造法 | |
| JPS6094091A (ja) | 光学活性カルボン酸エステルの製造法 | |
| EP1433857A1 (fr) | Procede de production de monomeres | |
| JP4392812B2 (ja) | 新規光学活性4−アミノ−2−メチル酪酸誘導体及びその製造方法 | |
| JPH0751533B2 (ja) | 光学活性なテルフェニル誘導体の製造法 | |
| WO2007132119A1 (fr) | Procede in situ ou 'one pot' d'hydrogenation et d'amination reductrice. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19871215 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 19900312 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Withdrawal date: 19901025 |
|
| R18W | Application withdrawn (corrected) |
Effective date: 19901025 |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: SIH, CHARLES, J. |
|
| RTI1 | Title (correction) |
Free format text: ENZYMATIC PROCESS FOR PREPARING OPTICALLY-ACTIVE 1,2-DIHYDRO-3H-PYRROLO 1,2A PYRROLE-1-CARBOXYLIC ACID DERIVATIVES |